Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,124.22, giving the company a market capitalization of 1.06T. It carries a P/E multiple of 38.20 and pays a dividend yield of 0.60%.
On 2026-09-10, Eli Lilly(LLY) stock traded between a low of $1,121.07 and a high of $1,139.50. Shares are currently priced at $1,124.22, which is +0.3% above the low and -1.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.12M, compared to an average daily volume of 2.54M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Eli Lilly and Nvidia both just posted stunning quarters riding two of the biggest secular waves in markets today, but a $10,000 bet can only tilt one way. Which...
Eli Lilly just crossed the trillion-dollar threshold on the back of a GLP-1 empire growing at nearly 50% annually, but a recent pullback and rising risks are fo...
HSBC raised the firm’s price target on Eli Lilly (LLY) to $940 from $850 and keeps a Reduce rating on the shares. The firm adjusted targets in the healthcare gr...
Analyst ratings
81%
of 32 ratingsMore LLY News
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
Eli Lilly & Co. (NYSE:LLY) stock is down about 2% on Tuesday as a broader risk-off move pressures large-cap healthcare stocks. The Nasdaq is down 0.29%, while t...
Key Points Eli Lilly's most important drugs right now are Mounjaro, Zepbound, and, to a lesser degree, Foundayo. The company's dominant GLP-1 weight-loss drug...
The adage that "birds of a feather flock together" doesn't always apply to billionaire investors. Most of these super-successful individuals have their own uniq...
Eli Lilly (LLY) is back in focus after releasing 52 week data from its TOGETHER psoriasis and psoriatic arthritis trials, which tested Taltz with obesity drug Z...
Key Points The company's GLP-1 therapies are adding indications. Lilly's growing revenue has allowed it to invest heavily in its pipeline. The company has se...
Key Points Eli Lilly hasn't split its stock in nearly 30 years, but as shares trade above $1,000, the pharmaceutical company could be considering one. Conside...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.